Since AML with mutated NPM1 frequently harbors FLT3 mutations, which have been previously reported to be associated with higher CD123 expression [29,30], we also analyzed the FLT3 mutational status in 122 samples. The gene discussed is FLT3; the disease is acute myeloid leukemia.